These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25604386)

  • 1. A Hyaluronic Acid-Conjugated Gadolinium Hepatocyte-Specific T1 Contrast Agent for Liver Magnetic Resonance Imaging.
    Moon M; Thomas RG; Heo SU; Park MS; Bae WK; Heo SH; Yim NY; Jeong YY
    Mol Imaging Biol; 2015 Aug; 17(4):497-503. PubMed ID: 25604386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The performance of gadolinium diethylene triamine pentaacetate-pullulan hepatocyte-specific T1 contrast agent for MRI.
    Yim H; Yang SG; Jeon YS; Park IS; Kim M; Lee DH; Bae YH; Na K
    Biomaterials; 2011 Aug; 32(22):5187-94. PubMed ID: 21561660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
    Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
    J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium-Labeled Biodegradable Dendron-Hyaluronic Acid Hybrid and Its Subsequent Application as a Safe and Efficient Magnetic Resonance Imaging Contrast Agent.
    Guo C; Sun L; Cai H; Duan Z; Zhang S; Gong Q; Luo K; Gu Z
    ACS Appl Mater Interfaces; 2017 Jul; 9(28):23508-23519. PubMed ID: 28656751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and evaluation of VEGFR-targeted macromolecular MRI contrast agent based on biotin-avidin-specific binding.
    Liu Y; Wu X; Sun X; Wang D; Zhong Y; Jiang D; Wang T; Yu D; Zhang N
    Int J Nanomedicine; 2017; 12():5039-5052. PubMed ID: 28765707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronic acid-functionalized single-walled carbon nanotubes as tumor-targeting MRI contrast agent.
    Hou L; Zhang H; Wang Y; Wang L; Yang X; Zhang Z
    Int J Nanomedicine; 2015; 10():4507-20. PubMed ID: 26213465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic-contrast-enhanced magnetic resonance imaging of cirrhotic liver parenchyma: A comparison between gadolinium-diethylenetriamine pentaacetic acid and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid.
    Lin CY; Chang WC; Chou CT; Chen RC
    J Chin Med Assoc; 2015 Nov; 78(11):666-72. PubMed ID: 26341453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paramagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agents.
    Mikawa M; Kato H; Okumura M; Narazaki M; Kanazawa Y; Miwa N; Shinohara H
    Bioconjug Chem; 2001; 12(4):510-4. PubMed ID: 11459454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadolinium Complex of 1,4,7,10-Tetraazacyclododecane-1,4,7-trisacetic Acid (DO3A)-Ethoxybenzyl (EOB) Conjugate as a New Macrocyclic Hepatobiliary MRI Contrast Agent.
    Baek AR; Kim HK; Park S; Lee GH; Kang HJ; Jung JC; Park JS; Ryeom HK; Kim TJ; Chang Y
    J Med Chem; 2017 Jun; 60(12):4861-4868. PubMed ID: 28530407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the intestinal and hepatic uptake/efflux transport of the magnetic resonance imaging contrast agent gadolinium-ethoxylbenzyl-diethylenetriamine-pentaacetic acid.
    Jia J; Puls D; Oswald S; Jedlitschky G; Kühn JP; Weitschies W; Hosten N; Siegmund W; Keiser M
    Invest Radiol; 2014 Feb; 49(2):78-86. PubMed ID: 24056116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injectable hyaluronic acid hydrogels with the capacity for magnetic resonance imaging.
    Bermejo-Velasco D; Dou W; Heerschap A; Ossipov D; Hilborn J
    Carbohydr Polym; 2018 Oct; 197():641-648. PubMed ID: 30007657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel redox-sensitive system based on single-walled carbon nanotubes for chemo-photothermal therapy and magnetic resonance imaging.
    Hou L; Yang X; Ren J; Wang Y; Zhang H; Feng Q; Shi Y; Shan X; Yuan Y; Zhang Z
    Int J Nanomedicine; 2016; 11():607-24. PubMed ID: 26917960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-EpCAM scFv gadolinium chelate: a novel targeted MRI contrast agent for imaging of colorectal cancer.
    Khantasup K; Saiviroonporn P; Jarussophon S; Chantima W; Dharakul T
    MAGMA; 2018 Oct; 31(5):633-644. PubMed ID: 29737435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Bifunctional Gadolinium-Labeled Superparamagnetic Nanoparticles (Gd-MnMEIO) for In Vivo MR Imaging of the Liver in an Animal Model.
    Kuo YT; Chen CY; Liu GC; Wang YM
    PLoS One; 2016; 11(2):e0148695. PubMed ID: 26886558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid-ceramide-based optical/MR dual imaging nanoprobe for cancer diagnosis.
    Cho HJ; Yoon HY; Koo H; Ko SH; Shim JS; Cho JH; Park JH; Kim K; Kwon IC; Kim DD
    J Control Release; 2012 Aug; 162(1):111-8. PubMed ID: 22709587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo magnetic resonance imaging of mice liver tumors using a new gadolinium-based contrast agent.
    Chen SH; Kuo YT; Cheng TL; Chen CY; Chiu YY; Lai JJ; Chang CC; Jaw TS; Wang YM; Liu GC
    Kaohsiung J Med Sci; 2013 May; 29(5):246-53. PubMed ID: 23639510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gd (III) complex conjugate of low-molecular-weight chitosan as a contrast agent for magnetic resonance/fluorescence dual-modal imaging.
    Huang Y; Boamah PO; Gong J; Zhang Q; Hua M; Ye Y
    Carbohydr Polym; 2016 Jun; 143():288-95. PubMed ID: 27083371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary on "A Microfluidic Platform to Design Crosslinked Hyaluronic Acid Nanoparticles (cHANPs) for Enhanced MRI".
    Russo M; Bevilacqua P; Netti PA; Torino E
    Mol Imaging; 2017 Jan; 16():1536012117706237. PubMed ID: 28654388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual targeted therapy of hepatic cancer using homing peptide modified calcium phosphate nanoparticles loading doxorubicin guided by T1 weighted MRI.
    Zhang NN; Yu RS; Xu M; Cheng XY; Chen CM; Xu XL; Lu CY; Lu KJ; Chen MJ; Zhu ML; Weng QY; Hui JG; Zhang Q; Du YZ; Ji JS
    Nanomedicine; 2018 Oct; 14(7):2167-2178. PubMed ID: 30017962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body MRI with assessment of hepatic and extraabdominal enhancement after administration of gadoxetic acid for staging of rectal carcinoma.
    Huppertz A; Franiel T; Wagner M; Püttcher O; Wagner J; Rief M; Schwenke C; Hamm B; Strassburg J
    Acta Radiol; 2010 Oct; 51(8):842-50. PubMed ID: 20698804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.